InnoCare Pharma Ltd
InnoCare Pharma's GHG Emissions Data Preview
In 2023, InnoCare Pharma completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).
However, InnoCare Pharma has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into InnoCare Pharma's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of InnoCare Pharma amounted to 12,134.54 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of InnoCare Pharma increased by 23.37%, suggesting that the company faced challenges in reducing its emissions from its core operations.
InnoCare Pharma's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are InnoCare Pharma's Scope 1 emissions?
In 2023, the total Scope 1 emissions of InnoCare Pharma were 19.95 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
What are InnoCare Pharma's Scope 2 emissions?
In 2023, InnoCare Pharma reported Scope 2 greenhouse gas (GHG) emissions of 12,114.59 tCOâ‚‚e without specifying the calculation method.
Has InnoCare Pharma reduced its Scope 2 emissions over time?
Since 2020, InnoCare Pharma's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have increased by 389.16%, reflecting a rising long-term trend in Scope 2 emissions over time.
Compared to the previous year (2022), InnoCare Pharma's Scope 2 emissions (Unspecified Calculation Method) rose by 23.17% in 2023, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy
What methodology does InnoCare Pharma use for Scope 2 reporting?
In 2023, InnoCare Pharma reported its Scope 2 emissions using an unspecified methodology.
InnoCare Pharma's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)